Effect of Hepatitis C Drugs on Blood Coagulability in Patients on Warfarin Using the Medical Information Database Network (MID-NET®) in Japan.

Sono SawadaTakashi AndoMai HiranoNoriyuki KomiyamaToyotaka IguchiYukio OniyamaChieko IshiguroYoshiaki Uyama

Published in: Therapeutic innovation & regulatory science (2021)

The analysis of MID-NET® data provides useful information on drug safety assessment of real-world patients. The results of this study imply that fluctuation of the liver function test results may relate to the fluctuation of blood coagulability in patients on both DAA and warfarin. This study contributes to a deeper understanding of the usefulness and limitations of real-world data in MID-NET® for regulatory purposes.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
emergency department
venous thromboembolism
patient reported outcomes
electronic health record
transcription factor
social media